NCT04148729View on ClinicalTrials.gov

USG Guided ESP Block in Spinal Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 20, 2019

Primary Completion Date

November 20, 2020

Study Completion Date

December 20, 2020

Conditions
Postoperative Pain
Interventions
DRUG

ESP block

Ultrasound guided ESP block will perform with 15 ml bupivacaine+ 5 ml lidocaine at the T10 level bilaterally. 0.1 microgram morphine (IV) and diclofenac sodium 75 mg intramuscularly will perform for postoperative analgesia.

DRUG

Control Group

In this group Ultrasound guided ESP block will not perform. Postoperative analgesia will provide with 0.1 microgram morphine (IV) and diclofenac sodium 75 mg intramuscularly.

Trial Locations (1)

01380

Çukurova University, Adana

All Listed Sponsors
lead

Cukurova University

OTHER

NCT04148729 - USG Guided ESP Block in Spinal Surgery | Biotech Hunter | Biotech Hunter